Fibrogenesis in chronic allograft rejection: underlying mechanisms and pharmacological control (Q34996895)

5 August 2017

1 reference

title

Fibrogenesis in chronic allograft rejection: underlying mechanisms and pharmacological control (English)

1 reference

5 August 2017

E M Eugui

1

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

Transplantation Proceedings

5 August 2017

published in

1 reference

5 August 2017

volume

34

1 reference

5 August 2017

issue

7

1 reference

5 August 2017

page(s)

2867-2871

1 reference

Quantitation of allograft fibrosis and chronic allograft nephropathy.

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(02)03539-X

7 January 2021

Renal fibrosis: an update

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(02)03539-X

7 January 2021

The renal tubulointerstitium in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(02)03539-X

7 January 2021

International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(02)03539-X

7 January 2021

Chronic allograft rejection

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(02)03539-X

7 January 2021

Mechanisms of action of mycophenolate mofetil in preventing chronic rejection

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(02)03539-X

7 January 2021

Fibrogenic and other biological effects of silica.

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(02)03539-X

7 January 2021

Fibroblast chemotaxis induction by human recombinant interleukin-4. Identification by synthetic peptide analysis of two chemotactic domains residing in amino acid sequences 70-88 and 89-122.

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(02)03539-X

7 January 2021

Silica-stimulated monocytes release fibroblast proliferation factors identical to interleukin 1. A potential role for interleukin 1 in the pathogenesis of silicosis

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(02)03539-X

7 January 2021

Interleukin 1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(02)03539-X

7 January 2021

Maitotoxin and P2Z/P2X(7) purinergic receptor stimulation activate a common cytolytic pore

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(02)03539-X

7 January 2021

Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction Rapid Communication

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(02)03539-X

7 January 2021

Sequential cytokine expression in renal allografts in rats immunosuppressed with maintenance cyclosporine or mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(02)03539-X

7 January 2021

Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(02)03539-X

7 January 2021

Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(02)03539-X

7 January 2021

Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(02)03539-X

7 January 2021

The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(02)03539-X

7 January 2021

Cyclosporine induces the expression of the cyclin inhibitor p21

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(02)03539-X

7 January 2021

Mechanism of the combination immunosuppressive effects of rapamycin with either cyclosporine or tacrolimus

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(02)03539-X

7 January 2021

Rapamycin induces transforming growth factor-beta production by lymphocytes

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(02)03539-X

7 January 2021

Cyclosporine induces cancer progression by a cell-autonomous mechanism.

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(02)03539-X

7 January 2021

Transforming growth factor-beta stimulates the expression of endothelin mRNA by vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(02)03539-X

7 January 2021

Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Témoin de l'Infarctus du Myocarde (ECTIM) Study

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(02)03539-X

7 January 2021

TGF-beta1 DNA polymorphisms, protein levels, and blood pressure

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(02)03539-X

7 January 2021

Transforming growth factor-beta1 and lung allograft fibrosis

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(02)03539-X

7 January 2021

10.1016/S0041-1345(02)03539-X

Identifiers

DOI

1 reference

5 August 2017

1 reference